AKT1 and breast carcinoma: By combining differential expression analysis, enrichment analysis, and molecular docking, we identified several key toxicological targets and signaling pathways altered by PCBs in breast cancer, notably the PI3K-Akt and MAPK pathways, highlighting their essential roles in the disease’s pathology.